A major advance in cancer study is emerging with the use of VHH fragments to re-engage mutated p53. This crucial tumor suppressor protein is frequently inactivated in various forms of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research